Product Program year 2025 Source: CMS Open Payments

Neospan

Device In2bones

PDI 00817906020083

Open in the dashboard

General payments

$119,123

333 payments

Research payments

$0

0 payments

Through program year 2025, $119,123 in general payments and $0 in research payments were reported against Neospan (In2bones).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $119,123 333

Breakdown

Who paid General payments · program year 2025
  1. Linvatec Corporation $119,123 333 payments
Top recipients General payments · program year 2025
  1. Taggart Gauvain Foot and Ankle Surgery · Pearland, TX $16,622 14% · 10 payments
  2. Justin Weatherall Orthopaedic Surgery · Deerfield Beach, FL $16,295 14% · 13 payments
  3. Matthew Dzurik Podiatrist, Foot & Ankle Surgery · Wilmington, NC $15,794 13% · 6 payments
  4. Jefferson Sabatini Foot and Ankle Surgery · Huntsville, AL $10,722 9% · 10 payments
  5. Harvey Montijo Orthopaedic Surgery · Royal Palm Beach, FL $9,608 8% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Podiatrist, Foot & Ankle Surgery Podiatrist $41,632 35% · 109 practitioners
  2. Orthopaedic Surgery $35,405 30% · 22 practitioners
  3. Foot and Ankle Surgery Orthopaedic Surgery $30,488 26% · 24 practitioners
  4. Podiatrist $7,595 6% · 50 practitioners
  5. Podiatrist, Primary Podiatric Medicine Podiatrist $1,080 <1% · 9 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $30,172 25% · 36 recipients
  2. North Carolina $22,848 19% · 15 recipients
  3. Texas $20,924 18% · 26 recipients
  4. Alabama $10,739 9% · 2 recipients
  5. Pennsylvania $10,662 9% · 11 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

333 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record